Merck's rotavirus vaccine approved by FDA

02/4/2006 | San Francisco Chronicle

The FDA approved Merck's RotaTeq vaccine against rotavirus, a virus that affects most young children and often is fatal in developing countries. In response to problems with an earlier vaccine, Merck and competitor GlaxoSmithKline conducted trials to ensure their vaccines do not cause dangerous obstructions of the intestine.

View Full Article in:

San Francisco Chronicle

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ